Long-Term PSA Control with Repeated Stereotactic Body Radiotherapy in a Patient with Oligometastatic Castration-Resistant Prostate Cancer

Publisher： Karger

E-ISSN： 2296-5262|39|4|217-220

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.39, Iss.4, 2016-03, pp. : 217-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Disease Stabilization in a Patient with Castration-Resistant Metastatic Prostate Cancer by the Addition of Lenalidomide to Low-Dose Dexamethasone and Celecoxib

By  

Oncology Research and Treatment, Vol. 35, Iss. 5, 2012-04 ,pp. : 279-282

Karger

Access to resources Recommend Favorite

Methylselenocysteine preventing castration‐resistant progression of prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. : 1001-1008

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Immunotherapy in Castration‐Resistant Prostate Cancer (CRPC)

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 367-375

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Palliative Surgery in Castration-Resistant Prostate Cancer

By  

Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. : 670-677

Karger

Access to resources Recommend Favorite

Simultaneous chylothorax and chylous ascites in a patient with castration‐resistant prostate cancer after docetaxel chemotherapy: An unusual manifestation

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 614-614

John Wiley & Sons Inc

Access to resources Recommend Favorite